On the evening of October 29, Mei Nian Da Health Industry Holdings Co., Ltd. (hereinafter referred to as “Mr. Healthâ€) issued a third quarterly report. The report showed that the company’s performance in the first three quarters continued to grow at a high rate, with a total operating income of 581,869.37. Ten thousand yuan, an increase of 43.04% over the same period of the previous year, net profit of 413,873,100 yuan, an increase of 68.18% over the same period of the previous year. In the same period, the US Announcement of Health, the company's 300-500 million yuan share repurchase program has been reviewed and approved by the board of directors on the same day.
Revenue and profit growth
The US Three-Year Health Report showed that from January to September 2018, the company achieved a total operating income of RMB 5.8,863.7 million, an increase of 43.04% over the same period of the previous year; and realized a net profit attributable to shareholders of listed companies of 41,387. 310,000 yuan, an increase of 68.18% over the same period of the previous year. The company expects to achieve a net profit of 82,000-88,000 yuan in 2018, an increase of 41.30%-51.64% over the same period of the previous year.
Insiders pointed out that the key growth factors of the health of the United States are reflected in four aspects. First, the company accelerates the layout of the medical examination center and deepens the multi-brand operation strategy. Second, it continuously introduces high-end medical examination products, and the ratio of individual inspections and per capita customer price increases. Third, adhere to the quality control upgrade, increase the strength and management weight of the branch's compliance operation, medical quality norms and personnel training; Fourth, launch innovative products such as good doctors in the United States, and greatly expand and enhance the income growth space.
Mei Nian Health Company said that in 2018, under the guidance of the “prevention-oriented†national health strategy, the company accelerated the layout of the medical examination center and basically achieved the layout goals of 600 professional medical examination centers nationwide, covering all provinces except Hong Kong, Macao and Taiwan. City Autonomous Region. At the same time, the company deepened the multi-brand operation strategy, comprehensively served the public health, continuously consolidated the development of the group inspection market, and actively expanded the inspection market, and in line with the people's health consumption upgrade, and constantly launched capsule gastrointestinal mirror, genetic testing, coronary NMR, AD The advanced high-end medical examination products such as early detection and fundus artificial intelligence greatly enriched the connotation of the medical examination package, which made the proportion of individual inspections and per capita customer price increase rapidly.
In terms of product and service innovation, on October 25th, Midea Health recently teamed up with Ping An Good Doctor and PICC to launch a highly innovative heavyweight health management product, “Mr. Good Doctorâ€, from a single medical examination service to “checking, The whole process of protection, management, medical care and insurance, namely comprehensive medical examination, health banking, health consultation, medical treatment and insurance protection, leaping and implementing the whole process of health management before, during and after inspection, is praised by the industry as “ Create a new era of 3.0 health management." The product integrates the resources of the top three hospitals in key cities, provides consumers with green channel services such as medical consultation, appointment, hospitalization, etc., and through the telemedicine platform “Elephant Doctorâ€, enables consumers to “face to face†with national famous doctors. In addition, “Mr. Goodyear Doctor†and China PICC have joined forces to use the post-test major illness insurance, review cost insurance, and physical examination accident insurance to achieve health management throughout the life cycle.
"The core factor of performance growth is the increase in volume and price. It can be seen that the products of the company are committed to effectively improving the stickiness of C-side customers and effectively increase the unit price of C-end customers. The company's future revenue will be greatly increased. After joining insurance claims , reducing operational risks, but also giving the company more focus on strategy, product innovation and quality management," industry analysts pointed out.
According to the reporter's understanding, according to the overall strategic deployment of the US health, the company is stepping up its efforts on the compliance operation of the branch, medical quality standards and personnel training, and strengthening the investment in information construction management and the construction of medical professionals. Not long ago, Mei Nian Health participated in Aidi Kang, integrated its scientific research capabilities in medical testing, further improved the quality standards for inspection, increased the authority and professionalism of medical examination reports, further improved the internal control system, and continuously improved service quality and medical care. quality level.
The value of the consumption upgrade platform is highlighted
At the same time as the disclosure of the third quarterly report, Mei Nian Health also issued a notice to repurchase shares in a centralized bidding manner. The total amount of funds for repurchase is RMB 300 million to RMB 500 million, and the repurchase price does not exceed RMB 17 yuan per share. The purchase period is within 6 months from the date of review and approval of the repurchase program by the company's general meeting of shareholders. According to the maximum amount of share repurchase of RMB 50,000, and the repurchase price limit of RMB 17 per share, the estimated number of shares repurchased is 29,411,764 shares, accounting for 0.94% of the company's total share capital.
Midyear Health said that the repurchase shares will all be used for employee stock ownership plans or equity incentive plans. Recently, the health of the US is significantly reduced by the overall market. The stock is generally considered to be seriously undervalued. The company's move is regarded as “double boosting both inside and outsideâ€, which not only conveys the confidence of the market to the long-term optimism about the company and the industry, but also expresses its confidence to employees. The determination to share the fruits of business development.
The Southwest Medical Analysis Report pointed out that the value of the health flow import in the United States is gradually being realized, and the closed loop of the big health industry is worth looking forward to. According to the report, the physical examination flow has channel value for the front-end manufacturing industry and data entry value for the back-end service. The company is promoting the establishment of professional health insurance companies and third-party payment license applications, and is expected to achieve a closed loop from prevention, medical care to payment.
In recent years, the importance of preventive medicine, disease screening, and health management has reached an unprecedented level. With the continuous improvement of the public health concept, the medical health needs are blown out, and the local medical examination institutions have a hot queue for appointments. While consolidating and developing the dominant position of the first and second lines, the US Year will accelerate the sinking of the third and fourth-tier cities, promote the re-upgrading of medical examination services, enrich the service connotation, and realize the business objectives of increasing volume and price. At present, the United States has nearly 600 medical and physical examination centers in more than 200 core cities across the country, and has become the world's largest preventive medicine platform and health demand entrance. In 2018, the health of the United States will provide professional health services for nearly 30 million people, and it is expected to reach 100 million in 2021.
It is understood that relying on massive and accurate health check data, the US Health has a first-mover advantage in precision prevention and post-test services. At present, the company has taken the lead in obtaining technical advantages in the fields of health big data development and application, brain health testing, precision lung cancer early screening, diabetes intelligent management, AI fundus examination, 3D bone health and intelligent Chinese medicine physical examination, and will continue to strengthen artificial intelligence and genes. Core track innovation capabilities such as detection, early tumor screening, and advanced diagnosis. The company said that in the future, it will continue to focus on the front-end prevention link, and through the continuous improvement of the quality of professional medical examinations, strengthen the prevention and control, prevention, education and management of chronic diseases discovered after physical examination and diseases that threaten life and health. The gate moves forward.
As China's largest leading enterprise in preventive medicine, Midea Health takes the lead in laying out the construction of the ecological circle, and proposes to rely on the health check-up platform of the United States to focus on building traffic portals, accurate data, offline outlets and channel influence, and gradually build a win-win cooperation. The industry platform has gradually formed a strategic plan for the super ecosystem of the medical and health industry.
The industry believes that there must be a long-term thinking in the layout of the medical and health industry. The platform ecosystem of the medical and health industry needs to have two factors: one is the large enough institutional volume and the client scale; the other is the health import flow value and the industry extension depth. . As the largest health demand platform in China, the United States has always adhered to the core development strategy of “doing the main business, establishing the ecology, and completing the closed loopâ€, and carried out the core strategy around the three elements of “revenue growth, quality control upgrade, and technological innovationâ€. After upgrading, the unique dual-loop drive “scale-flow-data-technology-ecology†and “brand-talent-capital†are mutually integrated, empowering each other and continuously improving their professional standards and service capabilities through technological innovation. At present, Midea Health has strategically placed its leading position in core inspections such as professional inspection, advanced diagnosis, accurate assessment, genetic testing, data mining, telemedicine, health management, specialist chronic disease, Chinese medicine services, and health insurance.
Yu Rong, chairman of Mei Nian Health, pointed out that the consumption concept in the health field is different from the general public consumption logic. The more the economic down cycle, the more people pay attention to healthy consumption. At present, the consumption upgrading of the health prevention industry is the trend of the times. It is the most explosive "locomotive" in the big health industry. It was originally "treated" and now it is "precaution first". How to better meet the health needs of consumers? The health management of the whole life cycle, to prevent the port from moving forward, the use of the US's huge operating system, massive health data, resources to help the national public health reform, and save the national medical expenditure is the focus of the research and development of the healthy future of the United States.
Podiatry Autoclave,Dental Steam Sterilizer,Dental Autoclave For Sale,Autoclave Dental Instruments
ZHEJIANG FOMOS MEDICAL TECHNOLOGY CO.,LTD. , https://www.ifomos.com